Madrid, Spain

Jaime Priego

This inventor holds 4 USPTO granted patents. Top assignees: Alter, S.a., Other. Active years: 1988-1997.


% Patents Active = 100.0

Average Co-Inventor Count = 5.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 1988-1997

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Innovations by Inventor Jaime Priego

Introduction

Jaime Priego is a notable inventor based in Madrid, Spain. He has made significant contributions to the field of chemistry, particularly in the development of new pharmaceutical compounds. With a total of 4 patents, his work focuses on innovative solutions for medical treatments.

Latest Patents

Priego's latest patents include the development of 1,4-dihydropyridine derivatives, which are crucial for treating hypertension. These compounds exhibit a vasodilatory effect, making them suitable for managing high blood pressure. Additionally, some derivatives have a vasoconstrictory effect, which can be beneficial in treating hypotension. Another significant patent involves 1,4-dihydropyridine compounds with PAF-antagonistic activity. These compounds are designed to treat various pathologic states and disorders, including inflammatory processes and immunodeficient syndromes.

Career Highlights

Throughout his career, Jaime Priego has worked with various companies, including Alter, S.A. His innovative research has led to advancements in pharmaceutical chemistry, contributing to the development of effective treatments for several medical conditions.

Collaborations

Priego has collaborated with notable professionals in his field, including Carlos Sunkel and Miguel Fau De Casa-Juana. These partnerships have enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Jaime Priego's contributions to the field of chemistry and pharmaceuticals are noteworthy. His innovative patents and collaborations reflect his commitment to advancing medical treatments. His work continues to influence the industry positively.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…